|Moderated By: Sultan -- (Not Moderated) -- Started: 7/30/2011 2:52:54 AM Revision History|
Neptune Technologies & Bioressources Inc. researches, develops and commercializes proprietary bioactive
ingredients and products with the goal of superior added-value and clinically proven health benefits. The
Company extracts a range of bioactive ingredients such as novel proprietary omega-3 phospholipids from
abundant yet underexploited marine biomass including Krill, a cold deep water zooplankton. Neptune’s
first commercially available product is Neptune Krill Oil (NKO®), which represents marine based omega-3
phospholipids with potential in cardiovascular, cognitive and anti-inflammatory disorders. Neptune is pursuing
market opportunities in the nutraceutical market including dietary supplements and functional foods. The
Company is also pursuing opportunities in the pharmaceutical market through its pharmaceutical subsidiaries,Acasti and NeuroBioPharm (including medical food, over-the-counter and prescription drug applications).
NOTE: Neptune trades on Toronto.. For Canadian quote, enter NTB.TO
Acasti Pharma Inc. is 58% owned by Neptune.. For Canadian quote, go to APO.V
Copyright © 1995-2013 Knight Sac Media. All rights reserved.